RFA
CSCI

Reilly Financial Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Reilly Financial Advisors’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-130
Closed -$6K – 1059
2020
Q4 		$6K Buy
130
+60
+86% +$2.22K ﹤0.01% 698
2020
Q3 		$2K Buy
+70
New +$3.1K ﹤0.01% 777

Other funds holding CSCI

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Reilly Financial Advisors's CSCI Position: Q1 2021 in Review

Reilly Financial Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2021, closing a stake of 130 shares — an estimated $6K sold.

Reilly Financial Advisors first reported a position in CSCI in Q3 2020 and held it in 2 quarters. The position peaked at $6K in Q4 2020. 31 funds tracked by Wall St. Rank hold CSCI as of Q1 2021.

  • Reilly Financial Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Reilly Financial Advisors sold 130 COSCIENS Biopharma Inc. Common Stock shares in Q1 2021, an estimated $6K.
  • Reilly Financial Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Reilly Financial Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $6K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2021.

Based on Reilly Financial Advisors's 13F filing for Q1 2021, filed 22 Apr 2021.